357 related articles for article (PubMed ID: 32264967)
1. Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions.
Sugihara T; Hasegawa H; Uchida HA; Yoshifuji H; Watanabe Y; Amiya E; Maejima Y; Konishi M; Murakawa Y; Ogawa N; Furuta S; Katsumata Y; Komagata Y; Naniwa T; Okazaki T; Tanaka Y; Takeuchi T; Nakaoka Y; Arimura Y; Harigai M; Isobe M;
Arthritis Res Ther; 2020 Apr; 22(1):72. PubMed ID: 32264967
[TBL] [Abstract][Full Text] [Related]
2. Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study.
Muratore F; Boiardi L; Restuccia G; Cavazza A; Catanoso M; Macchioni P; Spaggiari L; Cimino L; Aldigeri R; Pipitone N; Fontana A; Casali M; Croci S; Salvarani C
Semin Arthritis Rheum; 2020 Aug; 50(4):549-558. PubMed ID: 32446023
[TBL] [Abstract][Full Text] [Related]
3. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.
Alibaz-Öner F; Kelesoglu B; Balci MA; Yardimci GK; Armağan B; Kiliç L; Karakaş Ö; Erden A; Yasar Bilge S; Kardaş RC; Küçük H; Zengin O; Tasci M; Kocaer SB; Yavuz S; Dogru A; Şahin M; Bayindir O; Sevik G; Ertürk Z; Alpay-Kanitez N; Gogebakan H; Tezcan ME; Oksuz MF; Cefle A; Kucuksahin O; Yazici A; Kasapoglu E; Bes C; Unal AU; Dalkiliç E; Yildirim Çetin G; Aksu K; Keser G; Onen F; Çobankara V; Kisacik B; Onat AM; Öztürk MA; Kaşifoğlu T; Omma A; Karadag O; Ates A; Direskeneli H
Clin Exp Rheumatol; 2024 Apr; 42(4):816-821. PubMed ID: 37976117
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
Emamifar A; Ellingsen T; Hermann AP; Hess S; Gerke O; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Thye-Rønn P
Sci Rep; 2021 Mar; 11(1):6220. PubMed ID: 33737697
[TBL] [Abstract][Full Text] [Related]
5. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
6. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A
Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008
[TBL] [Abstract][Full Text] [Related]
7. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
8. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
9. Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis.
Sugihara T; Uchida HA; Yoshifuji H; Maejima Y; Naniwa T; Katsumata Y; Okazaki T; Ishizaki J; Murakawa Y; Ogawa N; Dobashi H; Horita T; Tanaka Y; Furuta S; Takeuchi T; Komagata Y; Nakaoka Y; Harigai M
Mod Rheumatol; 2023 Nov; 33(6):1145-1153. PubMed ID: 36218378
[TBL] [Abstract][Full Text] [Related]
10. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
[TBL] [Abstract][Full Text] [Related]
11. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
[TBL] [Abstract][Full Text] [Related]
12. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center.
Öztaş M; Özgül H; Seyahi E; Uğurlu S
Turk J Med Sci; 2022 Aug; 52(4):917-925. PubMed ID: 36326373
[TBL] [Abstract][Full Text] [Related]
13. Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.
Kermani TA; Warrington KJ; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; McAlear CA; Monach PA; Seo P; Merkel PA; Ytterberg SR;
J Rheumatol; 2015 Jul; 42(7):1213-7. PubMed ID: 25877501
[TBL] [Abstract][Full Text] [Related]
14. Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study.
Restuccia G; Boiardi L; Cavazza A; Catanoso M; Macchioni P; Muratore F; Soriano A; Cimino L; Aldigeri R; Crescentini F; Pipitone N; Salvarani C
J Autoimmun; 2017 Feb; 77():39-44. PubMed ID: 27742223
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
Front Immunol; 2019; 10():1981. PubMed ID: 31507597
[TBL] [Abstract][Full Text] [Related]
16. Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.
Tuckwell K; Collinson N; Dimonaco S; Klearman M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Unizony SH; Stone JH;
Semin Arthritis Rheum; 2017 Apr; 46(5):657-664. PubMed ID: 27998620
[TBL] [Abstract][Full Text] [Related]
17. [Management of polymyalgia rheumatica and large vessel vasculitis].
Hellmich B
Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature.
Loricera J; Tofade T; Prieto-Peña D; Romero-Yuste S; de Miguel E; Riveros-Frutos A; Ferraz-Amaro I; Labrador E; Maiz O; Becerra E; Narváez J; Galíndez-Agirregoikoa E; González-Fernández I; Urruticoechea-Arana A; Ramos-Calvo Á; López-Gutiérrez F; Castañeda S; Unizony S; Blanco R
Arthritis Res Ther; 2024 Jun; 26(1):116. PubMed ID: 38840219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
